Table 3.
Variables | Frail | Non-frail | Disabled | Non-disabled | ||||
---|---|---|---|---|---|---|---|---|
Adj. HR | (95% CI) | Adj. HR | (95% CI) | Adj. HR | (95% CI) | Adj. HR | (95% CI) | |
Multimorbidity | 1.02 | (0.81–1.28) | 1.34 | (1.01–1.82) | 1.37 | (0.90–2.09) | 1.10 | (0.90–1.35) |
Number of drugs | ||||||||
0–4: no polypharmacy | 1 | 1 | 1 | 1 | ||||
5–9: polypharmacy | 1.14 | (0.91–1.43) | 1.08 | (0.77–1.52) | 1.02 | (0.64–1.64) | 1.09 | (0.89–1.34) |
≥10: hyperpolypharmacy | 1.29 | (0.96–1.89) | 1.61 | (1.09–2.40) | 1.18 | (0.86–1.80) | 1.31 | (0.98–1.74) |
Adjusted for demographics, Cognitive Performance Scale, facilities are the shared frailty.